Intravascular catheter infections

Journal of Hospital Infection

Volumn 73, Issue 4, 2009, Pages 323-330

  Edgeworth, J ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Catheter related bloodstream infection; Cost benefit analysis; Infection control

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; BENZALKONIUM CHLORIDE; CEPHALOSPORIN; CHLORHEXIDINE; CIPROFLOXACIN; CITRIC ACID; GENTAMICIN; MICONAZOLE; MINOCYCLINE; NEOMYCIN; POVIDONE IODINE; RIFAMPICIN; SULFADIAZINE SILVER; TAUROLIDINE; VANCOMYCIN;

CATHETER INFECTION; COMORBIDITY; DIAGNOSTIC PROCEDURE; HOSPITAL PATIENT; HUMAN; IATROGENIC DISEASE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INTRAVASCULAR CATHETER; PRACTICE GUIDELINE; REVIEW;

BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; COST-BENEFIT ANALYSIS; HUMANS; INFECTION CONTROL;

EID: 71549127394     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.05.008     Document Type: Review

References (55)

1. Raad I., Hanna H., and Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7 (2007) 645-657
2. Jarvis W.R., Edwards J.R., Culver D.H., et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National nosocomial infections surveillance system. Am J Med 91 (1991) 185S-191S
3. Raad I.I., and Bodey G.P. Infectious complications of indwelling vascular catheters. Clin Infect Dis 15 (1992) 197-208
4. Lamas C., Boia M., and Eykyn S.J. Osteoarticular infections complicating infective endocarditis: a study of 30 cases between 1969 and 2002 in a tertiary referral centre. Scand J Infect Dis 38 (2006) 433-440
5. Lamas C.C., and Eykyn S.J. Bicuspid aortic valve - a silent danger: analysis of 50 cases of infective endocarditis. Clin Infect Dis 30 (2000) 336-341
6. Fowler Jr. V.G., Justice A., Moore C., et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 40 (2005) 695-703
7. Casey A.L., Mermel L.A., Nightingale P., and Elliott T.S. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 8 (2008) 763-776
8. Hockenhull J.C., Dwan K., Boland A., et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess 12 (2008) iii-iv xi-xii, 1-154
9. Safdar N., Fine J.P., and Maki D.G. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 142 (2005) 451-466
10. Timsit J.F. Diagnosis and prevention of catheter-related infections. Curr Opin Crit Care 13 (2007) 563-571
11. Crnich C.J., and Maki D.G. The role of intravascular devices in sepsis. Curr Infect Dis Rep 3 (2001) 496-506
12. Maki D.G., Kluger D.M., and Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81 (2006) 1159-1171
13. In: Wenzel R. (Ed). Prevention and control of nosocomial infections (2003), Lippincott Williams & Wilkins, Baltimore
14. Linares J., Sitges-Serra A., Garau J., Perez J.L., and Martin R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 21 (1985) 357-360
15. Maki D.G., Stolz S.M., Wheeler S., and Mermel L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 127 (1997) 257-266
16. Raad I., Costerton W., Sabharwal U., Sacilowski M., Anaissie E., and Bodey G.P. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168 (1993) 400-407
17. Bisognano C., Vaudaux P., Rohner P., Lew D.P., and Hooper D.C. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 44 (2000) 1428-1437
18. Stewart P.S., Rayner J., Roe F., and Rees W.M. Biofilm penetration and disinfection efficacy of alkaline hypochlorite and chlorosulfamates. J Appl Microbiol 91 (2001) 525-532
19. Francois P., Schrenzel J., Stoerman-Chopard C., et al. Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion. J Lab Clin Med 135 (2000) 32-42
20. Patti J.M., Allen B.L., McGavin M.J., and Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 48 (1994) 585-617
21. Gray E.D., Peters G., Verstegen M., and Regelmann W.E. Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1 (1984) 365-367
22. Rupp M.E., Ulphani J.S., Fey P.D., and Mack D. Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect Immun 67 (1999) 2656-2659
23. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23 (2002) 759-769
24. Edgeworth J.D., Treacher D.F., and Eykyn S.J. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 27 (1999) 1421-1428
25. Orsi G.B., Di Stefano L., and Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 23 (2002) 190-197
26. Pittet D., Tarara D., and Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. J Am Med Assoc 271 (1994) 1598-1601
27. Rello J., Ricart M., Mirelis B., et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 20 (1994) 94-98
28. Renaud B., and Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163 (2001) 1584-1590
29. Maki D.G., Weise C.E., and Sarafin H.W. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 296 (1977) 1305-1309
30. Pratt R.J., Pellowe C.M., Wilson J.A., et al. Epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 65 Suppl. 1 (2007) S1-64
31. Gastmeier P., and Geffers C. Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect 64 (2006) 326-335
32. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 (2006) 2725-2732
33. Department of Health UK. Going further faster: implementing the saving lives delivery programme. Saving lives: a delivery programme to reduce HCAI (2006), DoH, London
34. Ho K.M., and Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 58 (2006) 281-287
35. Walder B., Pittet D., and Tramer M.R. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 23 (2002) 748-756
36. Hanna H., Benjamin R., Chatzinikolaou I., et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 22 (2004) 3163-3171
37. Carratala J., Niubo J., Fernandez-Sevilla A., et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 43 (1999) 2200-2204
38. Garland J.S., Alex C.P., Henrickson K.J., McAuliffe T.L., and Maki D.G. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 116 (2005) e198-e205
39. Henrickson K.J., Axtell R.A., Hoover S.M., et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 18 (2000) 1269-1278
40. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 36 (2003) 1539-1544
41. Betjes M.G., and van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19 (2004) 1546-1551
42. Quarello F., and Forneris G. Prevention of hemodialysis catheter-related bloodstream infection using an antimicrobial lock. Blood Purif 20 (2002) 87-92
43. Marciante K.D., Veenstra D.L., Lipsky B.A., and Saint S. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control 31 (2003) 1-8
44. Shorr A.F., Humphreys C.W., and Helman D.L. New choices for central venous catheters: potential financial implications. Chest 124 (2003) 275-284
45. Veenstra D.L., Saint S., Saha S., Lumley T., and Sullivan S.D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. J Am Med Assoc 281 (1999) 261-267
46. Beyersmann J., Gastmeier P., Grundmann H., et al. Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 27 (2006) 493-499
47. Blot S.I., Depuydt P., Annemans L., et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 41 (2005) 1591-1598
48. Digiovine B., Chenoweth C., Watts C., and Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160 (1999) 976-981
49. Garrouste-Orgeas M., Timsit J.F., Tafflet M., et al. Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal. Clin Infect Dis 42 (2006) 1118-1126
50. Rello J. Impact of nosocomial infections on outcome: myths and evidence. Infect Control Hosp Epidemiol 20 (1999) 392-394
51. Soufir L., Timsit J.F., Mahe C., Carlet J., Regnier B., and Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 20 (1999) 396-401
52. Smith K., Gemmell C.G., and Hunter I.S. The association between biocide tolerance and the presence or absence of qac genes among hospital-acquired and community-acquired MRSA isolates. J Antimicrob Chemother 61 (2008) 78-84
53. Chatzinikolaou I., Hanna H., Graviss L., et al. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 24 (2003) 961-963
54. Leon C., Ruiz-Santana S., Rello J., et al. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med 30 (2004) 1891-1899
55. Sampath L.A., Tambe S.M., and Modak S.M. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 22 (2001) 640-646